
Conference: KSMCB 2026 INTERNATIONAL CONFERENCE
Date: October 5-8, 2026
Location: Daejeon Convention Center (DCC), Korea
Brief Introduction:
The 2026 International Conference will be held at the Daejeon Convention Center (DCC) from October 5th to 8th, with the support of Daejeon Metropolitan City and cooperation with the Daejeon-Sejong Biohealth Federation. Keynote speakers include Garry Nolan (Stanford University, USA), Detlef Weigel (Max Planck Institute, Germany), Mu-Ming Poo (Institute of Neuroscience of Chinese Academy of Science, China), Noboru Mizushima (University of Tokyo, Japan), Amy Keating (MIT, USA), and Ben Simons (University of Cambridge, UK). In addition to keynote lectures by world-class scholars, we will prepare a rich program that encompasses academic depth and industrial collaboration through 23 regular academic sessions, 7 new drug development and industry-academia collaboration sessions. In addition, we will prepare a company tour program for graduate students and postdoctoral researchers to support the career exploration and exchange of the next generation of researchers.

Conference: EACR 2026
Date: June 08-11, 2026
Location: Budapest, Hungary
Booth: 115
Brief Introduction:
The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Conference: AACR Annual Meeting 2026
Date: April 17-22, 2026
Location: San Diego, California
Booth: 4946
Brief Introduction:
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Conference: SITC’s 40th Anniversary Annual Meeting
Date: November 5-9, 2025
Location: National Harbor, MD
Booth: 333
Brief Introduction: Make your mark at the largest cancer immunotherapy conference and exhibit at SITC’s 40th Anniversary Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC’s Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.

Conference: EACR 2025
Date: June16-19, 2025
Location: Lisbon, Portugal
Booth: 96
Brief Introduction:
The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Conference: PEGS Boston 2025
Date: May 12-16, 2025
Location: Boston, MA
Booth: 318
Brief Introduction: The 2025 PEGS Boston Summit is set to build on the remarkable success of previous years, continuing its legacy as the premier event for biologics and protein engineering. Bringing together a global community of experts, innovators, and leaders in the field, the Summit will offer cutting-edge insights into the latest advances in drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. With over 300 presentations, breakout sessions, and interactive seminars, attendees will have unparalleled opportunities to network, learn, and engage in meaningful collaborations. The exhibit hall will once again feature top product and service providers, creating a gathering space for discovery, innovation, and fun. Join us at the PEGS Boston Summit to be part of the next wave of breakthroughs shaping the future of biologics.

Conference: AACR ANNUAL MEETING 2025
Date: April 25-30, 2025
Location: Chicago, Illinois
Booth: 4644
Brief Introduction: The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting showcases cutting-edge cancer science and medicine.

Conference: PEGS Boston 2024
Date: May 13-17, 2024
Location: Boston, MA
Booth: 510
Brief Introduction:
PEGS Boston is a leading biologics event that covers all aspects of biologics development, and provides in-depth coverage of protein and antibody engineering, antibody therapeutics, cancer immunotherapy research, protein expression, protein analytics, and more.

Conference: AACR ANNUAL MEETING 2024
Date: April 5-10, 2024
Location: San Diego Convention Center, San Diego, California
Booth: 1153
Brief Introduction:
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Conference: Discovery on Target
Date: September 25-28, 2023
Location: Boston, MA
Booth: 110
Brief Introduction: Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.